Abstract
This study describes a method for isolating two luteolin glycosides from artichokes(Cynara scolymus L.)by preparative liquid chromatography. The partion A27~29 (4 g) of 50% ethanol eluent was achieved by two steps, 70% ethanol extract of artichoke adsorbed by AB-8 macroporous resin and eluted with 20% ethanol, 50% ethanol and 80% ethanol successively. 0.32 g of target part C16~19 with target components H-01 (10.4%) and H-02 (5.1%) was achieved by two steps, A27~29 adsorbed by RP-C18 stationary phase column (270 mm×80 mm, 40~60 μm) and eluted with 30%, 48% and 100% methanol successively. Taking the resolution and shape of target peaks as optimization conditions, the effects of five different mobile phase combinations and two kinds of flow rates on the separation of target peaks were studied. Based on the optimal conditions, H-01 and H-02 with purity of 97.8% and 96.5%, respectively, were obtained. H-01 and H-02 were identified as luteolin-7-rutinoside and luteolin-7-O-β-D-glucoside, respectively, by mass spectrometry, 1H-NMR and 13C-NMR analysis. This method can effectively reduce the impurity level under the condition of high recovery, and provide a new method for the development of the separation and purification process of luteolin compounds.
Publication Date
3-28-2019
First Page
176
Last Page
181
DOI
10.13652/j.issn.1003-5788.2019.03.032
Recommended Citation
Mingyue, SHI; Qingming, CAO; Qun, LI; Wenhui, ZHONG; Yuanqing, WANG; Zhiwen, LIU; and Xiping, ZHANG
(2019)
"Optimization of two luteolin derivatives preparation from artichoke by HPLC,"
Food and Machinery: Vol. 35:
Iss.
3, Article 32.
DOI: 10.13652/j.issn.1003-5788.2019.03.032
Available at:
https://www.ifoodmm.cn/journal/vol35/iss3/32
References
[1] 王天轶, 王云志. 洋蓟叶提取物的生物活性研究[J]. 中草药, 2006, 37(8): 1 281-1 283.
[2] SALEM M B, AFFES H, KSOUDA K, et al. Pharmacological Studies of Artichoke Leaf Extract and Their Health Benefits[J]. Plant Foods for Human Nutrition, 2015, 70(4): 441-453.
[3] 徐琳琳, 曹建新. 朝鲜蓟的化学成分及药理活性研究进展[J]. 天然产物研究与开发, 2012, 24(8): 1 135-1 140.
[4] 师明月, 曹清明, 钟文惠, 等. 朝鲜蓟多酚类化合物研究进展[J]. 食品与机械, 2018, 34(12): 160-165.
[5] LATTANZIO V, KROON P A, LINSALATA V, et al. Globe artichoke: a functional food and source of nutraceutical ingredients[J]. Journal of Functional Food, 2009, 1(2): 131-144.
[6] KRAFT K. Artichoke leaf extract-recent findings reflecting effects on lipid metabolism, liver and gastrointestinal tracts[J]. Phytomedicine, 1997, 4(4): 369-378.
[7] SPERONI E, CERVELLATI R, GOVONI P, et al. Efficacy of different Cynara scolymus preparations on liver complaints[J]. Journal of ethnopharmacology, 2003, 86(2): 203-211.
[8] GEBHARDT R. Prevention of taurolithocholate-induced hepatic bile canalicular distortions by HPLC-characterized extracts of artichoke (Cynara scolymus) leaves[J]. Planta Medica, 2002, 68(9): 776-779.
[9] MICCADEI S, DI VENERE D, CARDINALI A, et al. Antioxidative and Apoptotic Properties of Polyphenolic Extracts from Edible Part of Artichoke (Cynara scolymus L.) on Cultured Rat Hepatocytes and on Human Hepatoma Cells[J]. Nutrition and Cancer, 2008, 60(2): 276-283.
[10] JIMENEZ-ESCRIG A, DRAGSTED L O, DANESHVAR B, et al. In vitro antioxidant activities of edible artichoke (Cynara scolymus L.) and effect on biomarkers of antioxidants in rats[J]. Journal of Agricultural and Food Chemistry, 2003, 51(18): 5 540-5 545.
[11] BUNDY R, WALKER A F, MIDDLETON R W, et al. Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: A randomized, double blind placebo controlled trial[J]. Phytomedicine, 2008, 15(9): 668-675.
[12] ENGLISCH W, BECKERS C, UNKAUF M, et al. Efficacy of Artichoke dry extract in patients with hyperlipoproteinemia[J]. Arzneimittel-Forschung, 2000, 50(3): 260-265.
[13] WALKER A F, MIDDLETON R W, PETROWICZ O. Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post-marketing surveillance study[J]. Phytotherapy Research, 2001, 15(1): 58-61.
[14] MISAEL P C E, DE GUADALUPE T, DEL CSGM P, et al. Effect of Cynara scolymus (artichoke) in homeopathic doses on body mass index in obese and overweight patients[J]. Biomed Pharmacol J, 2014, 7(2): 525-533.
[15] RONDANELLI M, OPIZZI A, FALIVA M, et al. Metabolic management in overweight subjects with naive impaired fasting glycaemia by means of a highly standardized extract from Cynara scolymus: A Double-blind, Placebo-controlled, Randomized Clinical Trial[J]. Phytotherapy Research, 2014, 28(1): 33-41.
[16] LOMBARDO S, PANDINO G, MAUROMICALE G, et al. Influence of genotype, harvest time and plant part on polyphenolic composition of globe artichoke [Cynara cardunculus L. var. scolymus (L.) Fiori][J]. Food Chemistry, 2010, 119(3): 1 175-1 181.
[17] ADZET T, CAMARASA J, LAGUNA J C. Hepatoprotective activity of polyphenolic compounds from Cynara scolymus against CCl4 toxicity in isolated rat hepatocytes[J]. Journal of Natural products, 1987, 50(4): 612-617.
[18] ROUPHAEL Y, BERNARDI J, CARDARELLI M, et al. Phenolic compounds and sesquiterpene lactones profile in leaves of nineteen artichoke cultivars[J]. Journal of Agricultural and Food Chemistry, 2016, 64(45): 8 540-8 548.
[19] CHO J Y, PARK J, YOO E S, et al. Inhibitory effect of sesquiterpene lactones from Saussurea lappa on tumor necrosis factor-α production in murine macrophage-like cells[J]. Planta medica, 1998, 64(7): 594-597.
[20] SHAKERI A, AMINI E, ASILI J, et al. Screening of several biological activities induced by different sesquiterpene lactones isolated from Centaurea behen L. andRhaponticum repens (L.) Hidalgo[J]. Natural Product Research, 2018, 32(12): 1 436-1 440.
[21] PANDINO G, LOMBARDO S, MAUROMICALE G, et al. Profile of polyphenols and phenolic acids in bracts and receptacles of globe artichoke (Cynara cardunculus var. scolymus) germplasm[J]. Journal of Food Composition and Analysis, 2011, 24(2): 148-153.
[22] SCHLUPPER D, GIESA S, GEBHARDT R. Influence of biotransformation of luteolin, luteolin 7-O-glucoside, 3′,4′-dihydroxyflavone, and apigenin by cultured rat hepatocytes on antioxidative capacity and inhibition of EGF receptor tyrosine kinase activity[J]. Planta Medica, 2006, 72(7): 596-603.
[23] GEBHARDT R. Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts[J]. Journal of Pharmacology and Experimental Therapeutics, 1998, 286(3): 1 122-1 128.
[24] RAHIMUDDIN S A, KHOJA S M, ZUHAIR M M, et al. Inhibition of lipid peroxidation in UVA-treated skin fibroblasts by luteolin and its glucosides[J]. European Journal of Lipid Science and Technology, 2007, 109(7): 647-655.
[25] 王中美, 张平喜, 李树举, 等. 朝鲜蓟种类及繁殖技术[J]. 湖南农业科学, 2015(5): 22-24.
[26] 张平喜, 王中美, 夏继国, 等. 朝鲜蓟‘洛尔卡(LORCA)’植物学特性及栽培技术[J]. 中国园艺文摘, 2014, 30(5): 175-177.
[27] PETROVIC S D, GORUNOVIC M S, WRAY V, et al. A taraxasterol derivative and phenolic compounds from Hieracium gymnocephalum[J]. Phytochemistry, 1999, 50(2): 293-296.
[28] SHABANA M, GONAID M, SALAMA M M, et al. Phenylalkylamine alkaloids from Stapelia hirsuta L[J]. Nat Prod Res, 2006, 20(8): 710-714.